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 H. influenzae carbonic anhydrase (HICA) is a β-carbonic anhydrase that is important 
to the survival of the human respiratory tract pathogen H. influenzae.  Although HICA 
shares a high degree of structural similarity with E. coli carbonic anhydrase (ECCA), HICA 
lacks ECCA’s nickel-binding capabilities.  However, previous research suggests that the 
engineering of histidine clusters on HICA through the mutation of surface residues enables 
HICA to gain nickel-binding ability similar to that of ECCA.  Here we present the production 
and analysis of a K129 L133 HICA double mutant.  Using PyMOL to visualize the mutant, it 
was determined that the mutated histidines form a cluster of four histidines which are all 
located between approximately 3.7 to 6.7 Å from each other.  The mutant plasmid was 
constructed using site-directed mutagenesis via megaprimer PCR, and then overexpressed 
in E. coli to obtain a protein lysate with a protein concentration of 16.23 ± 0.06 mg/mL.  
The ability of the mutant HICA protein to bind to nickel was analyzed using Ni-NTA 
chromatography, followed by SDS-PAGE analysis of the chromatography fractions.  The 
results of the SDS-PAGE analysis suggest that the mutant HICA protein bound weakly to the 
nickel column, requiring 25 mM imidazole to elute.   
 
 
Carbonic anhydrases are zinc metalloenzymes that catalyze the reversible 
interconversion of CO2 and bicarbonate: 
𝐶𝑂2 + 𝐻2𝑂 ⇌ 𝐻𝐶𝑂3
− + 𝐻+ 
Haemophilus influenzae carbonic anhydrase (HICA) is a member of the β-form of carbonic 
anhydrases, a class of enzymes found in bacteria, yeast, and plant chloroplasts (1). HICA is 
essential for the survival of nontypeable (unencapsulated) strains of H. influenzae bacteria 
in ambient air and intracellular survival in host cells.  These bacterial strains are one of the 
leading causes of noninvasive mucosal infections, such as otitis media, sinusitis, and 
conjunctivitis (2). Therefore, HICA could be a potential antibiotic target in the treatment of 
these infections.  However, the potential to carry out further research on HICA hinges on 
the ability to purify it in large quantities.   
  Purification of HICA and other proteins is commonly achieved by metal affinity 
chromatography after a histidine tag has been engineered onto the N-terminus or C-
terminus of the polypeptide chain.  Some advantages of this method are its ability to purify 
proteins in one step and the ease of imidazole elution.  However, drawbacks include 
potential interference of tags with quaternary structure or the introduction of random 
coiling that could interfere with downstream techniques.  If the tag is close to the active 
site, it could change the conformation of the protein, resulting in proteins that have lost 
their function.  Sometimes this can be fixed by moving the tag to the opposite terminus, but 
this does not always prove effective (1).   
 Since some E. coli proteins have been discovered that exhibit endogenous nickel 
affinity, it is possible that instead of engineering a terminal histidine tag, metal affinity 
could be engineered on the surface of a protein.  Since four of the six ligand positions on 
Ni2+ ions are usually occupied by other ligands, theoretically only two histidines may be 
necessary for nickel binding.  Based on known inorganic structures, the optimal distance 
between these two histidines is expected to be between 4 and 7 Å apart (1).  Although 
histidine tags are usually engineered with six adjacent histidines at the terminus, proteins 
could be engineered to have histidine clusters to mimic those of proteins with endogenous 
nickel affinity.  A better understanding of the parameters of histidine location on the 
surface of proteins required for metal-affinity chromatography would provide a broadly 
applicable technique for protein purification and eliminate the need to use histidine tags.  
To begin defining these parameters, proteins with endogenous metal affinity must first be 
examined.   
  One such protein that exhibits endogenous metal affinity and is closely related to 
HICA is E. coli carbonic anhydrase (ECCA), which has been shown to bind to so tightly to 
Ni2+ columns that 250 to 300 mM imidazole is needed to elute it (1).  Like other β-carbonic 
anhydrases, ECCA’s quaternary structure is a dimer of dimers.  The tetramerization 
interface between dimers is partially solvent exposed and contains two symmetry-related 
clusters of histidines.  Each cluster includes six histidines from two chains (His72, His122, 
and His160 from one chain; His720, His1220, and His1600 from the other chain).  Within 
the same chain, the histidines are between 5 and 7 Å apart, while the interchain distances 
are closer to 3.5 and 4.5 Å.  These side chains could be within the sphere of rotation 
necessary to optimize nickel coordination since nickel(II)–histidine coordination distances 
have been observed in protein structures at 1.8 to 2.4 Å (1).   
 Recognizing that HICA, while unable to bind to Ni2+, does share 38% identity, 
quaternary structure, and activity profile similar to ECCA, and only partially conserves the 
cluster of histidines in the tetramerization interface (His72, His122, and Arg160), Hoffman 
explored the possibility of mutating HICA’s Arg160 residue to histidine to recreate ECCA’s 
metal affinity.  While wildtype HICA does not bind to the nickel column, the Arg160 mutant 
was shown to elute with 190 mM imidazole, while ECCA elutes at 278 mM imidazole.  
Furthermore they reported that while optimizing Arg160His HICA’s purification to 
minimize secondary retention during the binding and wash steps meant that the protein 
variant eluted earlier in the gradient, the HICA mutant similarly achieved greater than 90% 
purity.  In addition, the surface mutations did not influence the overall structure or 
function of the HICA protein, since steady-state kinetic activity and oligomerization state 
were similar to that of wildtype HICA (1).   
 Using their work as a model, we wanted to explore the possibility of increasing the 
metal affinity of HICA by mutating other solvent-exposed residues besides Arg160.  We 
chose to engineer a double mutant in which both Lys129 and Leu133 residues were 
mutated to histidine, as these residues were present on the surface of the HICA protein and 
were located in close proximity (within 4.4 to 6.4 Å) to two other histidines.  The goal was 
for these four histidines to be close enough to form a cluster to optimize nickel 
coordination.  Here we report the successful generation of a K129 L133 mutant HICA 
protein, and its ability to bind weakly to the nickel columns, requiring 25 mM imidazole to 




Cultures – DH5α E. coli cells transformed with pHICA were obtained as frozen stock 
from the Hoffman laboratory.  Cells were taken from frozen stock and inoculated in LB 
medium containing 1% tryptone, 0.5% yeast extract, 1% NaCl, and 100 μg/mL ampicillin.  
Cultures were incubated in a roller drum for 23 hours at 37°C. 
Plasmid miniprep – A plasmid miniprep for the pHICA plasmid was performed using 
a Zymo Zyppy Plasmid Miniprep Kit from Zymo Research.   Kit instructions were followed 
with the only exception being that the samples were incubated with Zyppy Elution Buffer 
for 20 min instead of 1 min.  Plasmid DNA concentrations were determined via NanoDrop 
1000 Spectrophotometer (ThermoScientific) to be 95.7 ng/μL.  
Site-Directed Mutagenesis (3)– In order to amplify the mutation of interest to 
produce a megaprimer, a PCR mixture containing 3.83 ng/μL pHICA plasmid template, 1 
pmol/μL forward primer containing mutations (5’-GGTTTCATCACGGTCATCATCTCG-3’), 1 
pmol/μL reverse primer Phi2X (5’-AGCTTGCATGCCTGCCTGCAGTTATTATG-3’), 0.2 mM 
dNTP mix, Phusion HF Buffer, and 0.05 units/μL Phusion High-Fidelity DNA polymerase 
was made.  This sample underwent touchdown PCR (4) with the following protocol: one 
initial cycle at 95 °C for 2 min; 40 cycles of 95 °C for 30 sec, 65 °C for 30 sec (temperature 
lowered 0.5 °C per cycle), and 72 °C for 30 sec; one cycle at 72 °C for 10 min; then hold at 4 
°C.  The sample was run on a 1% agarose gel containing TAE (0.04 M Tris, 1 mM EDTA, 0.02 
M glacial acid).  In order to visualize the bands, 0.001 % SYBR Safe DNA gel stain from Life 
Technologies was used.  Bands were excised and purified using the Zymoclean Gel DNA 
Recovery Kit from Zymo Research.  Instructions were followed with the exception that 
incubation was performed using pre-warmed (48 °C) elution buffer and samples were 
incubated for 7 min.  
In order to amplify the entire HICA gene containing the mutation, a PCR sample 
containing 3.83 ng/μL pHICA template, 1 pmol/μL PhiQC primer (5’-
CACTGCATAATTCGTGTCGCTCAAGG-3’), a third of the megaprimer sample obtained from 
the previous round of PCR, 0.2 mM dNTP mix, Phusion HF Buffer, and 0.05 units/μL 
Phusion High-Fidelity DNA polymerase was made.  This sample underwent classic PCR, 
with an initial cycle at 95°C for 2 min; 30 cycles of 95°C for 30 sec, 55°C for 30 sec, and 72°C 
for 1 min; an extension cycle of 72°C for 10 min; and then a final cycle held at 4°C.  The 
sample was run on a 1% agarose gel containing TAE (0.04 M Tris, 1 mM EDTA, 0.02 M 
glacial acid).  In order to visualize the bands, 0.001 % SYBR Safe DNA gel stain from Life 
Technologies was used.  Bands were excised and purified using the Zymoclean Gel DNA 
Recovery Kit from Zymo Research.  Instructions were followed with the exception that 
incubation was performed using pre-warmed (48 °C) elution buffer and samples were 
incubated for 10 min.  
In order to amplify the entire pHICA plasmid containing the mutation, a PCR sample 
containing 3.83 ng/μL pHICA template, a third of the megaprimer sample obtained from 
the previous round of PCR, 0.2 mM dNTPs, Phusion HF Buffer, and 0.05 units/μL Phusion 
High-Fidelity DNA polymerase.  This sample underwent classic PCR, with an initial cycle at 
95°C for 2 min; 30 cycles of 95°C for 1 min, 60°C for 1 min, and 72°C for 5 min; an extension 
cycle of 72°C for 10 min; and then a final cycle held at 4°C.  The sample was run on a 0.8% 
agarose gel containing TAE (0.04 M Tris, 1 mM EDTA, 0.02 M glacial acid).  In order to 
visualize the bands, 0.001% SYBR Safe DNA gel stain from Life Technologies was used.  
Transformation of mutant pHICA into E. coli cells – In order to obtain a higher 
quantity of mutant pHICA plasmid, the plasmid was transformed into E. coli cells.  First, 
PCR samples were treated with 10 units of Dpn1 enzyme in order to digest the parent 
plasmid DNA.  Samples were then incubated for approximately 2.5 hours at 37°C.  
Following incubation, 2.5 μL of the Dpn1-treated sample was added to 50 μL of DH5α 
competent E. coli cells from Zymo Research Mix and Go E. coli Transformation Kit and 
Buffer Set.  Following a 30 min incubation on ice, samples were plated on pre-warmed LB + 
amp plates (100 μg/mL ampicillin) and incubated overnight at 37°C.  A transformant 
colony was inoculated in LB + amp medium and incubated overnight at 37°C.   
 Sequencing – To prepare a sample for sequencing, the liquid culture was centrifuged 
and the pellet was resuspended in 1 mL of LB + amp medium.  A plasmid miniprep was 
then performed on the sample using a Zymo Zyppy Plasmid Miniprep Kit.   Kit instructions 
were followed with the only exception being that the samples were incubated with pre-
warmed (48 °C) Zyppy Elution Buffer for 30 min instead of 1 min.  Plasmid DNA 
concentrations were determined via NanoDrop 1000 Spectrophotometer to be 29.0 ng/μL.  
The sample sent for sequencing contained 21.8 ng/μL plasmid DNA, 1.5 μM 
PRRXseqforward primer (5’-GGCTCGTATAATGTGTGGAATTG-3’), and TE buffer (10 mM 
Tris, 1 mM EDTA) to obtain a total volume of 20 μL.  The plasmid sample was shipped to 
the MGH Core Facility for sequencing.   
 Transformation of mutant pHICA plasmid into autolysis cells – In preparation for 
transformation, DH5α E. coli cells containing the mutant plasmid were inoculated in 5 mL 
LB + amp medium, incubated overnight at 37 °C, and then underwent a plasmid miniprep 
using a Zymo Zyppy Plasmid Miniprep Kit.   Kit instructions were followed with the only 
exception being that the samples were incubated with pre-warmed (48 °C) Zyppy Elution 
Buffer for 30 min instead of 1 min.  Mutant plasmid DNA concentrations were determined 
via NanoDrop 1000 Spectrophotometer to be 75.0 ng/μL.  A transformation mixture 
containing 3.57 ng/μL mutant plasmid and 50 μL of XJb Autolysis E. coli cells from Zymo 
Research was incubated on ice for 15 min, then plated on pre-warmed (37 °C) LB + amp 
plates.  The plates were incubated overnight at 37 °C. 
 Production scale overexpression of folded mutant HICA protein – LB + amp liquid 
cultures of XJb E. coli transformants with the mutant plasmid were pelleted at 8000 × g for 
5 min, then the pellets were resuspended in 10 mL LB + amp medium.  These cells were 
inoculated in medium containing 900 mL TB nutrient (1.33% w/v tryptone, 2.67% w/v 
yeast extract, 0.44% glycerol), 100 mL TB buffer (0.89 M phosphate, pH 8), ampicillin, and 
3 mM arabinose, and incubated for approximately 3 hours.  Then 0.2 mM IPTG was added 
to induce expression of the mutant protein.  Cells were incubated overnight with shaking at 
37°C.  Cells were harvested by centrifugation at 8000 × g for 10 min.  The resulting wet cell 
pellet weighed 10.488 g.  The pellet was frozen and then subsequently thawed to lyse cells. 
 Cell lysis – Cells were resuspended in ~3 mL extraction buffer (20 mM Tris, 200 mM 
NaCl, pH 8) per gram of cell pellet.  Half of a Pierce protease inhibitor mini-tablet from 
Thermo Scientific was added to the mixture, and the mixture was incubated at 37 °C with 
vigorous shaking until homogenous.  In order to reduce clumping, 16 units of DNAse I from 
New England BioLabs were added to the sample.  Following incubation, the mixture was 
centrifuged at 35,000 × g for 30 min.  The supernatant was then centrifuged for an 
additional 15 min at 35,000 × g.  
BCA assay – A BCA assay (5) was performed using the Pierce BCA Protein Assay Kit 
from Thermo Scientific to determine the protein concentration of the lysate containing 
soluble mutant HICA proteins.  Kit instructions were followed with the only exception 
being that the BSA standards were purchased rather than prepared.  The standards used 
were a set of BSA standards (concentrations ranging from 125 μg/mL to 2000 μg/mL) from 
Thermo Scientific.  In addition, the sample of unknown concentration (the lysate of soluble 
mutant HICA proteins) was diluted 1/20 so that the concentration would fall within the 
range of the standards.  Absorbance values at 562nm were obtained using a Cary 50.   
Ni-NTA Chromatography (6) – To prepare an equilibrated matrix, 2 mL of Ni-NTA 
slurry (1 mL bed volume) from Qiagen was centrifuged at 2500 rpm, the supernatant was 
removed, 4 mL of lysis buffer (20 mM Tris, 200 mM NaCl, pH = 8) was added, the mixture 
was inverted to mix, centrifuged again at 2500 rpm, and the supernatant was removed.  To 
this equilibrated matrix, 8 mL of protein lysate (thawed on ice) and 10 mM imidazole were 
added, and the mixture was incubated for 60 min with shaking at 4°C.  Following 
incubation, the lysate-Ni-NTA mixture was loaded into a column and the flow-through (the 
first 8 column volumes) was collected.  The next 15 column volumes were washed with 25 
mM imidazole, then 5 column volumes were washed with 50 mM imidazole, 5 column 
volumes were washed with 75 mM imidazole, 5 column volumes were washed with 100 
mM imidazole, 4 column volumes were eluted with 250 mM imidazole, 4 column volumes 
were eluted with 500 mM imidazole, and finally 3 column volumes were eluted with 2 M 
imidazole.  These fractions were collected for SDS-PAGE analysis.   
SDS-PAGE analysis – For SDS-PAGE analysis of the fractions from the Ni-NTA 
chromatography, Laemmli procedure (7) was followed with the exception that a 12.5% 
separating gel was prepared containing lower Tris buffer (1.5 M Tris, 0.4% SDS, pH = 8), 
12.5% acrylamide/0.33% bis-acrylamide, 0.03% ammonium persulfate, and 0.025% 
TEMED (N,N,N’,N’-tetramethylethylenediamine).  The stacking gel prepared contained 
upper Tris buffer (0.5 M Tris, 0.4% SDS, pH = 8), 3% acrylamide/0.08% bis-acrylamide, 
0.03% ammonium persulfate, and 0.1% TEMED. The samples contained Laemmli sample 
buffer (0.063 M Tris, 10% glycerol, 2 mM DTT, 2.3% SDS, 1% β-mercaptoethanol, pH = 6.8).  
Samples were incubated at 100 °C for 3 min.  Then the gel was run for approximately 5 
hours with a Tris/glycine reservoir buffer (0.025 M Tris, 0.192 M glycine, 0.1% SDS, pH = 
8.3) at 55 mamps for the separating gel and 30 for the stacking gel.  Following 
electrophoresis, the gel was stained overnight with 0.025% Coomassie Blue R-250 staining 
solution containing 40% MeOH and 7% HAc, and subsequently destained with a destaining 
solution containing 3% glycerol, 10% HAc, and 40% MeOH.  The destaining solution was 
changed twice over a 3 day period.  The gel was dried in a gel dryer for 2 hours at 80 °C and 




 PyMOL analysis – Analysis of the HICA protein in PyMOL revealed that residues 
K129 and L133 were viable for mutation to His because these residues were both within 
4.4 to 6.4 Å of pre-existing His residues (Fig. 1A).  If these residues were to be mutated to 
His, the estimated distances between the mutated His residues and the pre-existing His 
residues would be between 3.7 to 6.7 Å (Fig. 1B), so these residues could potentially form a 
His cluster that could bind to the nickel column. 
 Site-directed mutagenesis – In order to amplify a region of the HICA gene containing 
the K129 and L133 mutations, a PCR reaction was performed and the resulting product 
was run on a gel to verify the length of the DNA fragment produced.  The calculated size of 
the expected DNA fragment was 342 bp, and the PCR product appeared between 300 and 
400 bp on the DNA gel (Fig. 2A). 
 Using this PCR product that contained the K129 and L133 mutations as a 
megaprimer, another PCR reaction was performed in order to amplify the entire HICA gene 
containing the K129 and L133 mutations.  The result of this second PCR reaction was run 
on gel to verify that PCR produced the expected product.  The calculated size of the 
expected DNA fragment containing the entire HICA gene was 883 bp, and the PCR product 
appeared around 1,000 bp on the DNA gel (Fig. 2B). 
 Using this PCR product of the entire HICA gene containing the K129 and L133 
mutations as a megaprimer, another PCR reaction was performed in order to amplify the 
entire pHICA plasmid containing the K129 and L133 mutations.  The result of this third 
PCR reaction was run on a gel to verify that PCR produced the expected product.  The 
calculated size of the expected DNA fragment was approximately 5 kb, and while the PCR 
sample formed some smeared bands on the gel, there was a band around 6 kb that was 
assumed to be the mutant pHICA plasmid (Fig. 2C).  Sequencing of this plasmid confirmed 
that the K129 and L133 mutations were present. 
 BCA Assay – As shown in Fig. 3, a standard curve was created by plotting absorbance 
at 280nm vs. protein concentration of the BSA standards.  From the linear regression 
performed on the standard curve, the amount of protein in the cell lysate from the lysed 
XJb E. coli cells could be quantified.  The concentration of protein in the cell lysate was 
determined to be 16.23 ± 0.06 mg/mL.  However, this number represents the total protein 
concentration, not just the concentration of mutant HICA protein.   
 Ni-NTA Chromatography and SDS-PAGE analysis – Since the mutant protein has two 
extra His residues, it is expected to bind more tightly to a nickel column than the wildtype 
HICA protein, which is not retained by nickel columns (1). Ni-NTA chromatography was 
therefore carried out in order to assess the mutant HICA protein’s affinity for nickel.  
Though the elution profile shows a spike in absorbance at 280nm when 100 mM and 250 
mM imidazole solutions were applied to the column (Fig. 4), an SDS-PAGE analysis was 
necessary to determine whether or not these fractions contained the mutant HICA protein.  
The mutant protein was expected to be about 26 kDa.  Bright bands of around size were 
present in the SDS-PAGE gel in lanes that contained the cell extract, flow-through, and wash 
1, and very faint bands of this size appeared in the other lanes as well (Fig. 5).  These faint 
bands were deemed insignificant, as most of the protein eluted in the preceding lanes.  
Since wash 1 was a 25 mM imidazole wash, it was concluded that the mutant HICA protein 





FIGURE 1. Pymol images of mutated amino acids K129 and L133.  A, amino acid side 
chains before K129 and L133 residues mutated.  B, amino acid side chains after residues 
mutated to His.  Green-colored histidines are pre-existing proximal histidines, cyan-colored 
amino acids are the residues of interest for mutation, and yellow dotted lines indicate 





FIGURE 2. Gels for length verification for K129 L133 mutation region, HICA gene, and 
pHICA plasmid.  A, PCR products from the amplification of the K129 L133 mutation region.  
B, PCR products from the amplification of the HICA gene.  C, PCR products from the 





FIGURE 3. Standard curve for BCA assay.  Points represent data from the BSA standards.  






FIGURE 4. Ni-NTA chromatography elution profile.  The protein lysate sample 
containing the soluble mutant plasmid was passed through a Ni-NTA column (1 column 
volume = 1 mL).  The first 8 column volumes were flow-through and the following column 
volumes were washed with various concentrations of imidazole (see Table 1).   















































Total elution volume (mL)
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 FIGURE 5. SDS-PAGE analysis of Ni-NTA chromatography fractions.  Fractions from Ni-
NTA chromatography were run on a 12.5% separating SDS-PAGE gel, along with a 
BenchMark Pre-Stained Protein Ladder and cell extract from cell lysis (see Table 2 for 



























 In this study, we successfully generated a mutant HICA protein, in which the K129 
and L133 residues were mutated to histidines.  These residues were chosen for mutation 
because PyMOL analysis confirmed their location on the surface of the HICA protein, their 
close proximity (between 4.4 to 6.4 Å) to pre-existing histidine residues on the same chain, 
and an estimated proximity of between 3.7 to 6.7 Å to these same histidines following 
mutation of K129 and L133 to His (Fig. 1).  These distances between histidines were 
assumed to be favorable for nickel coordination based on previous research that 
demonstrated that distances of 5 to 7 Å between histidines on the same chain in ECCA were 
able to bind so strongly to the nickel column that the protein required 250 – 300 mM 
imidazole to elute (1).  Thus, the mutation of the K129 and L133 residues to His was 
predicted to optimize coordination to nickel, since the newly engineered His residues 
would be close enough to the pre-existing ones to form a cluster of histidines.  As it was 
previously demonstrated that mutating HICA’s Arg160 residue to His sufficiently recreated 
ECCA’s metal affinity (1), we knew that this method of engineering a histidine cluster was 
effective, however, we wanted to explore whether that cluster could be engineering on 
other locations on the solvent-exposed surface of HICA.  When exploring other areas of the 
surface of the protein, the K129 and L133 residues were also chosen based on the fact that 
they were far from the zinc-containing active site.  Therefore, mutation of this region would 
not be predicted to interfere with enzymatic function of the protein.   
 Although the K129 and L133 mutations were designed to generate a protein with 
favorable inter-histidine distances for nickel binding, our data suggest that our K129 L133 
mutant HICA protein exhibits weak nickel affinity.  From the SDS-PAGE results (Fig. 5), it 
appears that most of the mutant HICA protein elutes with only 25 mM imidazole, since the 
protein was only present in appreciable quantities in the cell extract, flow-through, and 25 
mM imidazole wash, and was present only negligibly in the washes and elutions of higher 
imidazole concentration.  However, there were no washes performed with concentrations 
below 25 mM imidazole, so it is possible that the mutant HICA protein would have eluted 
with even lower concentrations of imidazole.  This does not come close to recapitulating 
the nickel-binding affinity of ECCA, which requires 250 to 300 mM imidazole to elute (1).  
Our mutant was also much less effective than the Arg160His mutant, which required 190 
mM imidazole (1).  One hypothesis as to why our K129 L133 mutant HICA protein did not 
exhibit the strong nickel binding predicted could be that the mutations were not actually 
made to an area of the protein that was solvent-exposed.  Though PyMOL showed the 
region on the surface of the protein, it could be that the solvent does not actually penetrate 
into that groove in the protein.  Another reason could be that although there were four 
histidines in the cluster, they were not actually the right distances from each other, or there 
were not enough of them to bind to the Ni2+. 
Since we were unable to perform tests on the kinetic activity of our mutant HICA 
protein, we do not know if the mutation affected enzymatic activity.  However, we can infer 
from what we know about the HICA mechanism, that our mutation most likely did not 
affect the enzymatic activity, as the mutation was not made to the zinc-containing active 
site.  The fundamental structural unit of HICA is a dimer composed of two identical protein 
chains (8).  All β-carbonic anhydrases contain one zinc ion per monomer in a pseudo-
tetrahedral coordination environment of the type Cys2His(X), where X is water, an anion or 
an Asp residue.  HICA is a type II β-carbonic anhydrase, meaning that its active site zinc ion 
is coordinated to 4 protein ligands, Cys42, Asp44, His98, and Cys101.  HICA also has a 
narrow, hydrophobic active site cleft that lies along the dimer interface and leads to the 
active site zinc ion.  This zinc helps to catalyze the reaction: 
𝐶𝑂2 + 𝐻2𝑂 ⇌ 𝐻𝐶𝑂3
− + 𝐻+ 
In the forward reaction, CO2 is concentrated in the active site by association with 
hydrophobic residues that line that active site cleft.  The CO2 is then positioned for 
nucleophilic attack by a zinc-bound hydroxide ion, which is oriented by the Asp residue.  
The zinc-bound hydroxide undergoes a nucleophilic addition to CO2, converting it to a 
bicarbonate ion. The developing negative charge on the bicarbonate ion is stabilized by H-
bonding to a Gln 151’ residue.  Then water exchanges for bicarbonate at the zinc ion, and a 
proton is lost from the zinc-bound water to regenerate the zinc-bound hydroxide ion.  
Understanding this mechanism allowed us to choose mutation sites (K129 and L133) in the 
HICA monomer that were located far from the monomer’s zinc active site.  However, kinetic 
data still needs to be collected to ensure that enzymatic function was in fact undisrupted.   
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